title: [What is the value of tumor debulking and intraperitoneal cytostasis].
abstract: Local recurrences of intraperitoneal malignancies are mainly localized at the primary tumor site and the peritoneal surface. Surgical procedures alone are neither able to further reduce the development of local recurrence nor to treat the already established recurrent disease. In this situation intraperitoneal chemotherapy as an "adjuvant" treatment modality could be thought helpful. Experimental and clinical trials have shown that high doses of cytotoxic agents can be applied to the abdominal cavity with less systemic side effects. While the recent published data are not promising for gastrointestinal malignancies, they seem to be more encouraging for ovarian cancer.
authors.affiliation: Department Chirurgie der Universität, Kantonsspital, Basel.
authors.forename: U
authors.initials: U
authors.lastname: Laffer
authors.forename: C
authors.initials: C
authors.lastname: Knüsli
authors.forename: F
authors.initials: F
authors.lastname: Harder
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D010478:Chemotherapy, Cancer, Regional Perfusion; D003131:Combined Modality Therapy; D005260:Female; D005770:Gastrointestinal Neoplasms / Q000188:drug therapy* / Q000601:surgery*; D006801:Humans; D010051:Ovarian Neoplasms / Q000188:drug therapy / Q000601:surgery; D010534:Peritoneal Neoplasms / Q000188:drug therapy* / Q000601:surgery*; D013274:Stomach Neoplasms / Q000188:drug therapy / Q000601:surgery